Listing 3 - Actual negotiations

Indication:

Multiple Indications

Indication:

Paroxysmal nocturnal hemoglobinuria (PNH)

Indication:

Multiple Indications

Indication:

Multiple Indications

Indication:

Multiple Indications

Indication:

Multiple Indications

Indication:

Multiple Indications

Indication:

Adult patients with locally advanced unresectable or metastatic urothelial carcinoma (UC), harbouring susceptible fibroblast growth factor receptor (FGFR)3 genetic alterations, who have disease progression during or following at least one line of prior therapy including within 12 months of neoadjuvant or adjuvant therapy.

Indication:

Primary hypercholesterolemia

Indication:

Primary hypercholesterolemia (non-familial and heterozygous familial)